Customer Service: 1-888-991-2299



Sign In or Create an Account

Check back for future clinic updates

Liver Health Clinic

With Hepatitis C Screening by a London Drugs Specialty Pharmacist or Nurse


It is estimated that 250,000 to 400,000 Canadians have Hepatitis C. The Canadian Association for the Study of the Liver recommends that all individuals born between 1945 and 1975 be tested and screened for Hepatitis C.

Our pharmacists and nurses have been trained to perform the OraQuick® HCV Rapid Antibody Test Kit and provide one-on-one counselling on Hepatitis C, explanation of results, and how to handle positive results. The screening test result will be shared with your doctor or other primary care provider (when available and requested) and London Drugs pharmacists and nurses will help those with a positive result to receive further testing and necessary treatment by a liver specialist. London Drugs pharmacy team will provide support throughout the journey to cure with multiple touch points.

What is Hepatitis C?

Acute hepatitis occurs within the first six months following exposure to HCV. Approximately 15%-25% of infected individuals will be able to clear the virus from their bodies. The other 75%-85% who become infected will develop chronic hepatitis C, which can lead to serious liver disease.

About 70%-80% of the people who are infected with HCV do not develop symptoms. Those who do develop symptoms generally do so between 2 and 12 weeks following exposure.

When symptoms occur, they may include:

  • abdominal pain

  • clay-coloured bowel movements

  • dark urine

  • fatigue (constant tiredness or weakness)

  • fever

  • jaundice (yellowing of skin or whites of eyes)

  • joint pain

  • loss of appetite

  • nausea

  • vomiting

Long-term consequences of Hepatitis C

Of the people who develop chronic hepatitis, 5%-20% will develop cirrhosis (severe scarring of the liver) over a 20 to 30-year period. With each passing year, up to 6% of chronic hepatitis patients will develop liver failure, and up to 5% will develop liver cancer.


There are several treatment regimens available for chronic hepatitis C, and the cure rate is over 95%.

How is Hepatitis C contracted?

The primary route of transmission of the hepatitis C virus (HCV) is through blood-to-blood contact with an infected person or product.

You could be at risk for Hepatitis C, if you:

  • were born between 1945 and 1975

  • were born in or are a resident of a region where hepatitis C is more common (i.e., Central, East, or South Asia; Australasia or Oceania; Eastern Europe; Sub-Saharan Africa; or North Africa/Middle East)

  • received blood, blood products, or an organ transplant before 1992 in Canada

  • Have ever been stuck with a needle that had been exposed to hepatitis C positive blood

  • have had signs of liver disease (i.e., abnormal liver enzyme tests) or other infectious diseases (i.e., hepatitis B, HIV, etc.)

  • have received or are currently receiving kidney/hemodialysis treatment

  • have any tattoos or body piercings

  • engage in high-risk sexual activity (i.e., multiple partners, traumatic or rough sex, etc.)

  • have shared personal care items with someone who has hepatitis C (i.e., razors, toothbrush, etc.)

  • have taken an illicit drug, either by injection or intranasal use (past or present)

Ask your London Drugs pharmacist about Hepatitis C screening today. Together, we can eliminate Hepatitis C.




London Drugs logo

Legal Terms|Privacy Policy|Security Policy & Cookie Notice

© 2024 London Drugs. All rights reserved.

London Drugs logo
  • About Us
  • London Drugs Story
  • Corporate Info
  • Careers
  • Community
Legal Terms|Privacy Policy|Security Policy & Cookie Notice

© 2024 London Drugs. All rights reserved.